Back to funds

Avidity Partners Management LP

Updated 6 days ago

Managed by Avidity Partners Management Lp • Latest filing Q3 2026

Portfolio value
$488.2M
Q3 2026
Filings
4
Quarterly 13F history
Top-10 concentration
87.7%
Weight of largest holdings
Annualized return
—
Implied from 13F holdings

Portfolio value history

13F-disclosed portfolio value over 4 quarters

Show data table
PeriodPortfolio value
Q4 2025$346.7M
Q1 2026$441.9M
Q2 2026$624.4M
Q3 2026$488.2M

Top holdings

18 positions as of Q3 2026

View filing
D

DIANTHUS THERAPEUTICS INC

Value
$167.3M
Shares
1.90M
% Port
34.26%
C

CG ONCOLOGY INC

Value
$95.6M
Shares
1.35M
% Port
19.59%
O

ORUKA THERAPEUTICS INC

Value
$65.4M
Shares
785.4K
% Port
13.40%
C

CG ONCOLOGY INC

Value
$60.3M
Shares
850.0K
% Port
12.34%
J

JADE BIOSCIENCES INC

Value
$28.1M
Shares
2.00M
% Port
5.76%
E

ENLIVEN THERAPEUTICS INC

Value
$25.2M
Shares
550.0K
% Port
5.16%
?
7.N/A

PERSPECTIVE THERAPEUTICS INC

Value
$16.7M
Shares
6.07M
% Port
3.42%
A

AKTIS ONCOLOGY INC

Value
$9.4M
Shares
484.2K
% Port
1.93%
I

IMMUNIC INC

Value
$6.2M
Shares
669.9K
% Port
1.28%
M

MOBIA MED INC

Value
$3.1M
Shares
324.7K
% Port
0.63%
P

PALVELLA THERAPEUTICS INC NE

Value
$2.8M
Shares
20.0K
% Port
0.57%
N

NUVECTIS PHARMA INC

Value
$2.1M
Shares
100.4K
% Port
0.43%
M

SATELLOS BIOSCIENCE INC

Value
$1.4M
Shares
164.0K
% Port
0.29%
C

CONTEXT THERAPEUTICS INC

Value
$1.2M
Shares
4.06M
% Port
0.25%
K

KARYOPHARM THERAPEUTICS INC

Value
$1.1M
Shares
884.9K
% Port
0.22%
S

SENSEONICS HLDGS INC

Value
$1M
Shares
100.0K
% Port
0.21%
S

SCYNEXIS INC

Value
$759K
Shares
153.6K
% Port
0.16%
A

AVALYN PHARMACEUTICALS INC

Value
$570K
Shares
20.0K
% Port
0.12%

Explore